Anna Faivre
Overview
Explore the profile of Anna Faivre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faivre A, Dalga D, Consoli I, Kosinksi C, de Seigneux S, Collet T, et al.
Rev Med Suisse
. 2025 Feb;
21(907):388-392.
PMID: 40012426
Chronic kidney disease (CKD) is becoming increasingly common, and adequate nutrition is essential in the management of this condition. Current recommendations focus mainly on reducing protein intake and managing electrolyte...
2.
Faivre A, Verissimo T, de Seigneux S
Acta Physiol (Oxf)
. 2025 Jan;
241(2):e14263.
PMID: 39797499
Aim: Proteinuria is the most robust predictive factors for the progression of chronic kidney disease (CKD), and interventions targeting proteinuria reduction have shown to be the most effective nephroprotective treatments...
3.
Faivre A, Bugarski M, Rinaldi A, Sakhi I, Verissimo T, Legouis D, et al.
J Am Soc Nephrol
. 2024 Apr;
35(7):854-869.
PMID: 38652545
No abstract available.
4.
Faivre A, de Seigneux S
Curr Opin Nephrol Hypertens
. 2024 Apr;
33(4):414-419.
PMID: 38597413
Purpose Of Review: This review critically examines the role of hypoxia in chronic kidney disease (CKD). While traditionally viewed as detrimental, recent insights suggest a more nuanced understanding of hypoxia's...
5.
Legouis D, Rinaldi A, Malpetti D, Arnoux G, Verissimo T, Faivre A, et al.
iScience
. 2024 Mar;
27(3):109271.
PMID: 38487013
The application of single-cell technologies in clinical nephrology remains elusive. We generated an atlas of transcriptionally defined cell types and cell states of human kidney disease by integrating single-cell signatures...
6.
Agius T, Emsley R, Lyon A, MacArthur M, Kiesworo K, Faivre A, et al.
Nat Commun
. 2024 Feb;
15(1):1073.
PMID: 38316771
Dietary restriction promotes resistance to surgical stress in multiple organisms. Counterintuitively, current medical protocols recommend short-term carbohydrate-rich drinks (carbohydrate loading) prior to surgery, part of a multimodal perioperative care pathway...
7.
Sangla F, Verissimo T, Faivre A, Glauser T, Cheah S, Assouline B, et al.
Front Med (Lausanne)
. 2023 Oct;
10:1223862.
PMID: 37780556
No abstract available.
8.
Verissimo T, Dalga D, Arnoux G, Sakhi I, Faivre A, Auwerx H, et al.
Am J Physiol Renal Physiol
. 2023 Apr;
324(6):F532-F543.
PMID: 37102687
Phosphoenolpyruvate carboxykinase 1 (PCK1 or PEPCK-C) is a cytosolic enzyme converting oxaloacetate to phosphoenolpyruvate, with a potential role in gluconeogenesis, ammoniagenesis, and cataplerosis in the liver. Kidney proximal tubule cells...
9.
Faivre A, Dissard R, Kuo W, Verissimo T, Legouis D, Arnoux G, et al.
Nephrol Dial Transplant
. 2023 Apr;
38(10):2276-2288.
PMID: 37096392
Background: The roles of hypoxia and hypoxia inducible factor (HIF) during chronic kidney disease (CKD) are much debated. Interventional studies with HIF-α activation in rodents have yielded contradictory results. The...
10.
Siedlar A, Seredenina T, Faivre A, Cambet Y, Stasia M, Andre-Levigne D, et al.
Redox Biol
. 2023 Jan;
60:102609.
PMID: 36708644
Differentiation of fibroblasts to myofibroblasts is governed by the transforming growth factor beta (TGF-β) through a mechanism involving redox signaling and generation of reactive oxygen species (ROS). Myofibroblasts synthesize proteins...